Reasons for interruption of anti-tubercular treatment as reported by patients with tuberculosis admitted in a tertiarycare institute

Indian Journal of Tuberculosis

Volumn 58, Issue 1, 2011, Pages 11-17

  Gupta, Sweta ^a   Gupta, Sanjay ^a   Behera, Digamber ^a  

^a LRS Institute of Tuberculosis and Respiratory Diseases   (India)

Author keywords

Anti tubercular treatment (ATT); Treatment interruption; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ALCOHOLISM; ARTICLE; ATTITUDE TO HEALTH; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DRUG COST; DRUG WITHDRAWAL; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HEALTH EDUCATION; HEARING LOSS; HOSPITAL ADMISSION; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; NEPHROTOXICITY; PATIENT COMPLIANCE; RASH; RESTLESSNESS; SEIZURE; TERTIARY HEALTH CARE; TOXIC HEPATITIS; TREATMENT REFUSAL;

ADULT; ANTITUBERCULAR AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; TUBERCULOSIS; WITHHOLDING TREATMENT;

EID: 79955510586     PISSN: 00195707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. TB India 2009: RNTCP Status Report. Central TB Division, DGHS, Govt. of India.Global Tuberculosis Control - Epidemiology, Strategy, Financing. World Health Organization, 2009
2. Chatterjee C, Banerjee B, Dutt D, Pati RR, Mullick AK. A Comparative Evaluation of Factors & Reasons for Defaulting in Tuberculosis Treatment in the States of West Bengal, Jharkhand and Arunachal Pradesh. Indian J Tuberc 2003; 50: 17-21
3. Danilova I, Mitunina L, Urastova M, Stoyunin M, Shapkin V, Oswald G et al. Tuberculosis Treatment Interruptions -Ivanovo Oblast, Russian Federation, 1999. JAMA 2001; 285: 1953-1954
4. Driver CR, Matus SP, Bayuga S, Winters AI, Munsiff SS. Factors associated with tuberculosis treatment interruption in New York City. J Public Health Manag Pract 2005; 11(4): 361-368
5. Emmanuel AD, Godwin YA. Factors associated with tuberculosis treatment default and completion at the Effia-Nkwanta Regional Hospital in Ghana. Trans R Soc Trop Med Hyg 2005; 99: 827-832
6. Kaona FA, Tuba M, Siziya S, Sikaona L. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health 2004 Dec 29; 4: 68.
7. Chan-Yeung M, Noertjojo K, Leung CC, Chan SL, Tam CM. Prevalence and predictors of default from tuberculosis treatment in Hong Kong. Hong Kong Med J 2003 Aug; 9(4): 263-268.
8. Oliveira VL, da Cunha AJ, Alves R. Tuberculosis treatment default among Brazilian children. Int J Tuberc Lung Dis 2006; 10(8): 864-869.
9. Dodor EA. Tuberculosis treatment default at the communicable diseases unit of Effia-Nkwanta Regional Hospital: a 2-year experience. Int J Tuberc Lung Dis. 2004; 8(11): 1337-1341.
10. Tekle B, Mariam DH, Ali A. Defaulting from DOTS and its determinants in three districts of Arsi Zone in Ethiopia. Int J Tuberc Lung Dis 2002 Jul; 6(7): 573-579.
11. Demissie M, Kebede D. Defaulting from tuberculosis treatment at the Addis Ababa Tuberculosis Centre and factors associated with it. Ethiop Med J 1994; 32 (2): 97-106.
12. Chee CB, Boudville IC, Chan SP, Zee YK, Wang YT. Patient and disease characteristics, and outcome of treatment defaulters from the Singapore TB control unit- a one-year retrospective survey. Int J Tuberc Lung Dis.2000; 4(6): 496-503.
13. Tissera WAA. Non-Compliance with Anti-Tuberculous Treatment at Colombo Chest Clinic. NTI Bulletin 2003; 39: 5-9.
14. Jaggarajamma K, Sudha G, Chandrasekaran V, Nirupa C, Thomas A, Santha T et al. Reasons for non-compliance among patients treated under Revised National Tuberculosis Control Programme (RNTCP), Tiruvallur district, South India. Indian J Tuberc 2007; 54(3):130-135.
15. Wares DF, Singh S, Acharya AK, Dangi R. Non-adherence to tuberculosis treatment in the eastern Tarai of Nepal. Int J Tuberc Lung Dis 2003 Apr; 7(4):327-335.
16. Bam TS, Gunneberg C, Chamroonsawasdi K, Bam DS, Aalberg O, Kasland O, Shiyalap K et al. Factors affecting patient adherence to DOTS in urban Kathmandu, Nepal. Int J Tuberc Lung Dis 2006; 10(3):270-276.
17. Jakubowiak WM, Bogorodskaya EM, Borisov SE, Danilova ID, Lomakina OB, Kourbatova EV. Social support and incentives programme for patients with tuberculosis: experience from the Russian Federation. Int J Tuberc Lung Dis 2007; 11(11): 1210-1215.
18. th Tuberculosis and Chest Diseases Workers' Conference. Indian J Tuberc 1965; 12: 217
19. Mishra P, Hansen EH, Sabroe S, Kafle KK. Adherence is associated with the quality of professional-patient interaction in Directly Observed Treatment Short-course, DOTS. Patient Educ Couns 2006 Oct; 63 (1-2): 29-37.
20. O'Boyle SJ, Power JJ, Ibrahim MY, Watson JP. Factors affecting patient compliance with anti-tuberculosis chemotherapy using the directly observed treatment, short-course strategy (DOTS). Int J Tuberc Lung Dis 2002; 6(4): 307-312.
21. Hill PC, Stevens W, Hill S, Bah J, Donkor SA, Jallow A, Lienhardt C. Risk factors for defaulting from tuberculosis treatment: a prospective cohort study of 301 cases in the Gambia. Int J Tuberc Lung Dis 2005; 9(12): 1349-1354.
22. Jaiswal A, Singh V, Ogden JA, Porter JDH, Sharma PP, Sarin R et al: Adherence to tuberculosis treatment: lessons from the Urban setting of Delhi, India. Tropical Medicine and International Health. 2003; 8: 625-633
23. Khanna BK, Srivastava AK, Ali Mohd. Drug default in Tuberculosis. Indian J Tuberc 1977; 24: 121-126
24. Vijay S, Balasangameshwara VH and Srikantaramu N. Treatment Dynamics and Profile of Tuberculosis Patients under the District Tuberculosis Programme (DTP) - A Prospective Cohort Study. Indian J Tuberc 1999; 46: 239-249
25. Vijay S, Balasangameshwara VH, Jagannatha PS, Saroja VN, Kumar P. Defaults among Tuberculosis Patients treated under DOTS in Bangalore City: A search for Solution. Indian J Tuberc 2003; 50: 185-195